{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:28:47Z","timestamp":1790839727860,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":6819,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.micinf.2005.03.009","type":"journal-article","created":{"date-parts":[[2005,4,16]],"date-time":"2005-04-16T07:28:36Z","timestamp":1113636516000},"page":"962-967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Prime-boost immunisation strategies for tuberculosis"],"prefix":"10.1016","volume":"7","author":[{"given":"Helen","family":"McShane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.micinf.2005.03.009_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0167-5699(97)01201-2","article-title":"Gene vaccination: plasmid DNA is more than just a blueprint","volume":"19","author":"Tighe","year":"1998","journal-title":"Immunol. Today"},{"issue":"5388","key":"10.1016\/j.micinf.2005.03.009_bib2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.282.5388.476","article-title":"Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine","volume":"282","author":"Wang","year":"1998","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.micinf.2005.03.009_bib3","doi-asserted-by":"crossref","first-page":"11349","DOI":"10.1073\/pnas.93.21.11349","article-title":"Applications of pox virus vectors to vaccination: an update","volume":"93","author":"Paoletti","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Pt. 5","key":"10.1016\/j.micinf.2005.03.009_bib4","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1099\/0022-1317-79-5-1159","article-title":"Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine","volume":"79","author":"Blanchard","year":"1998","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.micinf.2005.03.009_bib5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nm0498-397","article-title":"Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara","volume":"4","author":"Schneider","year":"1998","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.micinf.2005.03.009_bib6","doi-asserted-by":"crossref","first-page":"7524","DOI":"10.1128\/JVI.73.9.7524-7532.1999","article-title":"Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen","volume":"73","author":"Hanke","year":"1999","journal-title":"J. Virol."},{"issue":"5514","key":"10.1016\/j.micinf.2005.03.009_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.292.5514.69","article-title":"Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA\/MVA vaccine","volume":"292","author":"Amara","year":"2001","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.micinf.2005.03.009_bib8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nm881","article-title":"Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans","volume":"9","author":"McConkey","year":"2003","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.micinf.2005.03.009_bib9","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1086\/315074","article-title":"Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S\/SBAS2, a recombinant Plasmodium falciparum malaria vaccine","volume":"180","author":"Lalvani","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.micinf.2005.03.009_bib10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/IAI.69.2.681-686.2001","article-title":"Enhanced immunogenicity of CD4(+) T-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis","volume":"69","author":"McShane","year":"2001","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.micinf.2005.03.009_bib11","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1128\/IAI.70.3.1623-1626.2002","article-title":"Protective immunity against Mycobacterium tuberculosis induced by dendritic cells pulsed with both CD8(+)- and CD4(+)-T-cell epitopes from antigen 85A","volume":"70","author":"McShane","year":"2002","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.micinf.2005.03.009_bib12","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1128\/IAI.69.5.3041-3047.2001","article-title":"Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting","volume":"69","author":"Tanghe","year":"2001","journal-title":"Infect. Immun."},{"issue":"4","key":"10.1016\/j.micinf.2005.03.009_bib13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0378-1135(03)00046-4","article-title":"Improved immunogenicity of DNA vaccination with mycobacterial HSP65 against bovine tuberculosis by protein boosting","volume":"93","author":"Vordermeier","year":"2003","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.micinf.2005.03.009_bib14","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1016\/S0264-410X(01)00109-8","article-title":"Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA","volume":"19","author":"Mollenkopf","year":"2001","journal-title":"Vaccine"},{"issue":"17","key":"10.1016\/j.micinf.2005.03.009_bib15","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1001\/jama.291.17.2086","article-title":"Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study","volume":"291","author":"Aronson","year":"2004","journal-title":"J. Am. Med. Assoc."},{"issue":"3","key":"10.1016\/j.micinf.2005.03.009_bib16","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.171.3.1602","article-title":"Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara","volume":"171","author":"Goonetilleke","year":"2003","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.micinf.2005.03.009_bib17","volume":"73","author":"Williams","year":"2004","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.micinf.2005.03.009_bib18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2567.2004.01903.x","article-title":"Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guerin","volume":"112","author":"Vordermeier","year":"2004","journal-title":"Immunology"},{"issue":"11","key":"10.1016\/j.micinf.2005.03.009_bib19","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.micinf.2005.03.009_bib20","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1099\/vir.0.19701-0","article-title":"A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans","volume":"85","author":"Mwau","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.micinf.2005.03.009_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2249.2003.02272","article-title":"Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria","volume":"134","author":"Weir","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.micinf.2005.03.009_bib22","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(02)08353-8","article-title":"BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies","volume":"359","author":"Black","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2005.03.009_bib23","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/IAI.70.2.672-678.2002","article-title":"Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis","volume":"70","author":"Brandt","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micinf.2005.03.009_bib24","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1128\/IAI.69.4.2714-2717.2001","article-title":"Boosting vaccine for tuberculosis","volume":"69","author":"Brooks","year":"2001","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.micinf.2005.03.009_bib25","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/IAI.69.6.4174-4176.2001","article-title":"Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis","volume":"69","author":"Feng","year":"2001","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.micinf.2005.03.009_bib26","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1046\/j.1365-2567.2003.01731.x","article-title":"Cytotoxic T-cell responses to Mycobacterium bovis during experimental infection of cattle with bovine tuberculosis","volume":"110","author":"Skinner","year":"2003","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.micinf.2005.03.009_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/intimm\/14.1.31","article-title":"Prime-boost immunization generates a high frequency, high-avidity CD8(+) cytotoxic T lymphocyte population","volume":"14","author":"Estcourt","year":"2002","journal-title":"Int. Immunol."},{"issue":"12","key":"10.1016\/j.micinf.2005.03.009_bib28","doi-asserted-by":"crossref","first-page":"6774","DOI":"10.4049\/jimmunol.171.12.6774","article-title":"Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers","volume":"171","author":"Pinto","year":"2003","journal-title":"J. Immunol."},{"issue":"14","key":"10.1016\/j.micinf.2005.03.009_bib29","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1128\/JVI.78.14.7392-7399.2004","article-title":"Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes","volume":"78","author":"Reyes-Sandoval","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.micinf.2005.03.009_bib30","doi-asserted-by":"crossref","unstructured":"V.S. Moorthy, et al., Phase 1 evaluation of 3 highly immunogenic prime-boost regimens, including a 12-month reboosting vaccination, for malaria vaccination in Gambian men, J. Infect. Dis. 189 (12) (2004 Jun 15) 2213\u20132219 (Epub 2004 May 24).","DOI":"10.1086\/421118"},{"issue":"12","key":"10.1016\/j.micinf.2005.03.009_bib31","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.4049\/jimmunol.172.12.7239","article-title":"Rapid development of T cell memory","volume":"172","author":"Wong","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.micinf.2005.03.009_bib32","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.4049\/jimmunol.166.9.5473","article-title":"Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules","volume":"166","author":"Eo","year":"2001","journal-title":"J. Immunol."}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457905000973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457905000973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:13:49Z","timestamp":1761142429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457905000973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":32,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S1286457905000973"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2005.03.009","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prime-boost immunisation strategies for tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2005.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}